March 19, 2018 by Jeffrey Woldt and Chain Drug Review
community pharmacy, Jeffrey Woldt, NACDS government affairs, NACDS RxImpact Day, National Association of Chain Drug Stores, pharmacy advocates, Tricare
2018, Issue 03-19-2018, Issues, Leading Headlines, Opinion
An understanding of the value created by the National Association of Chain Drug Stores’ annual RxImpact Day — for the policy makers and pharmacy advocates who participated, the pharmacy profession as a whole and, ultimately, patients across the country — came into sharp focus during the daylong series of meetings on Capitol Hill that is
March 13, 2018 by Chain Drug Review
Alex Gourlay, Chain Drug Review, CVS Health, H-E-B, Kevin Hourican, Martin Otto, National Association of Chain Drug Stores, Retailer of the Year awards, slideshow, Walgreens Boots Alliance
Leading Headlines, Slideshows
NEW YORK — At a reception in Manhattan this month, Chain Drug Review honored the recipients of the publication’s Retailer of the Year Awards. In the spotlight before a throng of their retail peers and supplier partners were Alex Gourlay, co-chief operating officer of Walgreens Boots Alliance (WBA), who was named Retailer of the Year; Kevin
March 2, 2018 by Chain Drug Review
Kevin Nicholson, NACDS, National Association of Chain Drug Stores, opioid abuse, opioid crisis, Steve Anderson, White House Opioid Summit
Leading Headlines, Pharmacy, Retail News
ARLINGTON, Va. — The National Association of Chain Drug Stores took part in yesterday’s White House Opioid Summit and continues to give retail pharmacy’s take on how to combat the opioid abuse epidemic. Kevin Nicholson, vice president of public policy and regulatory affairs at NACDS, represented the association at Thursday’s event, which featured panels on education, prevention,
February 26, 2018 by Brian Bossetta and Chain Drug Review
2018 NACDS Regional Chain Conference, Alex Gourlay, NACDS Retail Advisory Board, National Association of Chain Drug Stores, Steve Anderson
2018, Issue 02-26-2018, Issues, News
FORT LAUDERDALE, Fla. — As it marks 85 years of representing traditional drug stores, supermarkets and mass merchants with pharmacies and supplier partners, the National Association of Chain Drug Stores is looking forward — as it demonstrated during its 2018 NACDS Regional Chain Conference here earlier this month. One of the keynote speakers during the
February 26, 2018 by Jeffrey Woldt and Chain Drug Review
Jeffrey Woldt, NACDS Annual Meeting, NACDS RxImpact Day on Capitol Hill, NACDS Total Store Expo, National Association of Chain Drug Stores, Steve Anderson
2018, Issue 02-26-2018, Issues, Opinion
The National Association of Chain Drug Stores is gearing up for three big events in the coming months, each of which will offer stakeholders in community pharmacy an opportunity to advance the interests of their organization and the industry as a whole. Taken together, NACDS RxImpact Day on Capitol Hill, the NACDS Annual Meeting and
February 23, 2018 by Chain Drug Review
2018 NACDS RxImpact Day, 2018 NACDS RxImpact Day on Capitol Hill, NACDS members, NACDS RxImpact Day, National Association of Chain Drug Stores, pharmacy advocacy event, pharmacy advocates, Steve Anderson
Featured Articles, Leading Headlines, Retail News
ARLINGTON, Va. — Next month, the National Association of Chain Drug Stores will set an all-time high for reach and participation when pharmacy advocates head to Washington, D.C., for the 2018 NACDS RxImpact Day on Capitol Hill. NACDS said that at its 10th annual RxImpact Day lobbying drive, to be held March 7 and 8, more
February 22, 2018 by Chain Drug Review
2018 NACDS Regional Chain Conference, Alex Gourlay, Fruth Pharmacy, Lynn Fruth, NACDS, National Association of Chain Drug Stores, slideshow, Steve Anderson, Walgreens Boots Aliance
2018, Issue 02-26-2018, Issues, News, Slideshows
Executives from regional drug and supermarket chains from across the country met in Fort Lauderdale, Fla., earlier this month at the 2018 NACDS Regional Chain Conference. This year’s theme, “Igniting Possibilities,” underscored the opportunity for attendees to share insights and ideas, engage in business and benefit from strategy sessions conducted by peers. “I have a
February 12, 2018 by Geoff Walden and Chain Drug Review
B. Douglas Hoey, Centers for Medicare & Medicaid Services, DIR fees, direct and indirect remuneration fees, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, NCPA, PCMA, Pharmaceutical Care Management Association, Steve Anderson
2018, Issue 02-12-2018, Issues, News
ARLINGTON, Va. — The “untenable” procedures around direct and indirect remuneration fees (DIR fees) can be righted with measures reducing costs for beneficiaries and the government, while promoting a more quality-driven health care system, says the National Association of Chain Drug Stores. NACDS expressed that message in comments to the Centers for Medicare & Medicaid
February 12, 2018 by Brian Bossetta
2018 NACDS Annual Meeting, Jim Collins, NACDS, National Association of Chain Drug Stores, Peggy Noonan, Steve Anderson
2018, Issue 02-12-2018, Issues, News
ARLINGTON, Va. — The National Association of Chain Drug Stores has slated two top speakers for its Sunday Business Program at the 2018 NACDS Annual Meeting, which will be held April 21 to April 24 in Palm Beach, Fla. — Pulitzer-prize winning columnist Peggy Noonan and author and management educator Jim Collins. Noonan’s writing for
February 7, 2018 by Chain Drug Review
2018 NACDS Regional Chain Conference, Alex Gourlay, Dan Ferrara, DIR fees, National Association of Chain Drug Stores, Steve Anderson, Walgreens Boots Alliance, Wegmans Food Markets
Featured Articles, Leading Headlines, Retail News
FORT LAUDERDALE, Fla. — Pharmacy retailers and suppliers have a world of possibilities in front of them amid an evolving retail health care landscape, industry executives said at the 2018 NACDS Regional Chain Conference. The conference gathered regional drug and supermarket chains (four to 250 locations) with supplier partners that help meet their customers’ health and wellness
February 2, 2018 by Bill Schiffner
American Pharmacists Association, NACDS, National Association of Chain Drug Stores, National Conference of Pharmaceutical Organizations, opioid abuse, Steven Anderson, Thomas Menighan
Leading Headlines, Pharmacy, Retail News
WASHINGTON— Opioid abuse is a serious public health problem that has reached crisis levels across the United States, with more than 90 Americans dying each day from overdose of opioids, and many more becoming addicted. Recognizing the urgency and impact of this issue on the health of millions of patients across the country, a coalition
January 29, 2018 by Chain Drug Review
2018 NACDS Annual Meeting, NACDS Annual Meeting, National Association of Chain Drug Stores, Peggy Noonan, Steve Anderson
Leading Headlines, Retail News
ARLINGTON, Va. — Author and Wall Street Journal columnist Peggy Noonan will speak at the upcoming National Association of Chain Drug Stores Annual Meeting. NACDS said Monday that Noonan is scheduled for the first Business Program session on Sunday morning, April 22. As previously announced, author and business expert Jim Collins is set to speak in the second
January 25, 2018 by Chain Drug Review
2018 NACDS RxImpact Day, National Association of Chain Drug Stores, RxImpact Day on Capitol Hill, Steve Anderson
Leading Headlines, Retail News
ARLINGTON, Va. — This year, the National Association of Chain Drug Stores RxImpact Day on Capitol Hill will literally bring a nationwide voice to Washington, D.C. Steve Anderson, president and chief executive officer of NACDS, said Thursday that the 2018 NACDS RxImpact Day scheduled for March 7 and 8 will include pharmacy advocates from all 50
January 17, 2018 by Chain Drug Review
Centers for Medicare & Medicaid Services, DIR fees at the point of sale, Medicare Part D, Medicare Part D for 2019, NACDS, National Association of Chain Drug Stores, National Community Pharmacists Association, NCPA, Steve Anderson
Leading Headlines, Pharmacy, Retail News
WASHINGTON — The National Association of Chain Drug Stores and the National Community Pharmacists Association have submitted comments to the Centers for Medicare & Medicaid Services (CMS) as it mulls Medicare Part D prescription drug program changes for the 2019 contract year. NACDS said Wednesday that in its comments to CMS the association expressed support for and provided added input